Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Arrowhead Pharmaceuticals, Inc. (ARWR) had Debt to Equity Ratio of 0.46 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$27.77M |
|
$-175.24M |
|
-- |
|
$27.77M |
|
$193.32M |
|
$-165.55M |
|
$-13.54M |
|
$-179.09M |
|
$-179.09M |
|
$-178.65M |
|
$-178.65M |
|
$-178.65M |
|
$-178.65M |
|
$-165.55M |
|
$-161.08M |
|
139.04M |
|
139.04M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$946.92M |
|
$381.05M |
|
$433.69M |
|
$1.38B |
|
$194.53M |
|
$200.33M |
|
$666.28M |
|
$860.81M |
|
$519.81M |
|
$512.52M |
|
$519.81M |
|
138.14M |
|
| Cash Flow Statement Financials | |
$159.06M |
|
$-201.91M |
|
$70.34M |
|
$102.69M |
|
$129.79M |
|
$27.11M |
|
$44.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.87 |
|
-- |
|
-- |
|
0.28 |
|
|
Debt to Equity Ratio |
0.46 |
100.00% |
|
-596.21% |
|
-596.21% |
|
-- |
|
-644.97% |
|
-631.11% |
|
$143.88M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.86 |
|
31.44 |
|
-34.37% |
|
-34.86% |
|
-12.94% |
|
-24.81% |
|
$3.76 |
|
$1.03 |
|
$1.14 |
|